
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>International consensus on the diagnosis and management of dumping syndrome</title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>International consensus on the diagnosis and management of dumping syndrome</strong></summary>
            <div>
                <ul><li>- Nature Reviews Endocrinology | August 2020 | volume 16</li><li>- https://doi.org/10.1038/s41574-020-0357-5</li><li>- A Delphi consensus process with international multidisciplinary experts to develop uniform guidance on the definition, diagnosis, and management of dumping syndrome.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>- What is the diagnostic cutoff for a pulse rate increase in a modified OGTT for early dumping syndrome?</li><li>- What is the consensus diagnostic cutoff for hypoglycemia in a modified OGTT for late dumping syndrome?</li><li>- Which somatostatin analogue formulation is considered more effective for symptom control, short-acting or long-acting?</li><li>- What is the typical dose range for acarbose in treating late dumping syndrome?</li><li>- What is the most sensitive sign of early dumping syndrome during an OGTT?</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Definition & Symptoms</strong></summary>
            <div>
                <ul><li>- Dumping syndrome is a frequent complication of oesophageal, gastric, or bariatric surgery.</li><li>- It comprises a constellation of symptoms categorized as <b>early</b> or <b>late</b> dumping syndrome.</li></ul>
                
        <details>
            <summary><strong>Prevalence</strong></summary>
            <div>
                <ul><li>- Prevalence depends on the type of surgery and diagnostic criteria used.</li><li>- <b>Bariatric surgery</b> has become the <u>main cause</u> of postoperative dumping syndrome.</li></ul>
                
        <details>
            <summary><strong>Prevalence by Surgery Type</strong></summary>
            <div>
                <ul><li>- Vagotomy with pyloroplasty: <q>~20%</q></li><li>- Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy: <q>up to 40%</q></li><li>- Oesophagectomy: <q>up to 50%</q></li><li>- Also reported after Nissen fundoplication.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Classification</strong></summary>
            <div>
                <ul><li>- Symptoms can occur jointly or separately.</li></ul>
                
        <details>
            <summary><strong><b>Early</b> Dumping Syndrome</strong></summary>
            <div>
                <ul><li>- Occurs within <q>the first hour</q> after a meal.</li><li>- It is the <u>typical and most frequent</u> manifestation.</li></ul>
                
        <details>
            <summary><strong>Symptoms</strong></summary>
            <div>
                <ul><li>- A combination of gastrointestinal and vasomotor symptoms.</li></ul>
                
        <details>
            <summary><strong><u>Gastrointestinal</u> Symptoms</strong></summary>
            <div>
                <ul><li>- Abdominal pain & cramps</li><li>- Bloating</li><li>- Borborygmi (rumbling sounds)</li><li>- Nausea</li><li>- Diarrhoea</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><u>Vasomotor</u> Symptoms</strong></summary>
            <div>
                <ul><li>- Fatigue & desire to lie down</li><li>- Flushing & perspiration</li><li>- Palpitations & tachycardia</li><li>- Hypotension</li><li>- Rarely, syncope</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Late</b> Dumping Syndrome</strong></summary>
            <div>
                <ul><li>- Occurs <q>1–3 hours</q> after a meal.</li><li>- Characterized by <b>(reactive) hypoglycaemia</b>.</li><li>- Also referred to as 'postbariatric hypoglycaemia'.</li></ul>
                
        <details>
            <summary><strong>Symptoms</strong></summary>
            <div>
                <ul><li>- Manifestations of hypoglycaemia due to neuroglycopenia and autonomic activation.</li></ul>
                
        <details>
            <summary><strong><u>Neuroglycopenic</u> Symptoms</strong></summary>
            <div>
                <ul><li>- Fatigue & weakness</li><li>- Confusion</li><li>- Hunger</li><li>- Syncope</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><u>Autonomic/Adrenergic</u> Symptoms</strong></summary>
            <div>
                <ul><li>- Perspiration</li><li>- Palpitations</li><li>- Tremor</li><li>- Irritability</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Clinical Impact</strong></summary>
            <div>
                <ul><li>- Symptoms are often debilitating and emotionally distressing.</li></ul>
                
        <details>
            <summary><strong>Quality of Life</strong></summary>
            <div>
                <ul><li>- In severe cases, associated with a <b>substantial reduction</b> in quality of life.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Weight Loss</strong></summary>
            <div>
                <ul><li>- In severe cases, can lead to considerable weight loss due to <u>food avoidance</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Pathophysiology</strong></summary>
            <div>
                <ul><li>- Caused by changes in gastric anatomy and innervation, allowing undigested food to reach the small intestine too rapidly.</li></ul>
                
        <details>
            <summary><strong><b>Early</b> Dumping Syndrome Mechanisms</strong></summary>
            <div>
                <ul><li>- A cascade of events activated by the rapid passage of nutrients to the small intestine.</li></ul>
                
        <details>
            <summary><strong>Mechanical Factors</strong></summary>
            <div>
                <ul><li>- <b>Reduced gastric volume capacity</b> (e.g., sleeve gastrectomy).</li><li>- <b>Removal of pyloric barrier function</b> (e.g., gastrectomy).</li><li>- These lead to rapid delivery of undigested food.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Fluid Shift</strong></summary>
            <div>
                <ul><li>- Hyperosmolar contents in the small intestine trigger a fluid shift from the intravascular space to the intestinal lumen.</li><li>- This leads to <u>decreased circulating blood volume</u>, causing tachycardia and hypotension.</li><li>- Intestinal distention contributes to cramps, bloating, and diarrhoea.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Hormonal Release</strong></summary>
            <div>
                <ul><li>- Rapid nutrient delivery triggers the release of several GI hormones.</li><li>- These contribute to both gastrointestinal and cardiovascular effects.</li></ul>
                
        <details>
            <summary><strong>Key Hormones Involved</strong></summary>
            <div>
                <ul><li>- <b>Vasoactive agents</b>: <q>neurotensin, vasoactive intestinal peptide (VIP)</q></li><li>- <b>Incretins</b>: <q>glucagon-like peptide 1 (GLP1), glucose-dependent insulinotropic polypeptide (GIP)</q></li><li>- <b>Glucose modulators</b>: <q>insulin, glucagon</q></li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Late</b> Dumping Syndrome Mechanisms</strong></summary>
            <div>
                <ul><li>- Primarily driven by a hyperinsulinaemic response to carbohydrate ingestion.</li></ul>
                
        <details>
            <summary><strong>Hyperinsulinaemic Hypoglycaemia</strong></summary>
            <div>
                <ul><li>- Rapid delivery of carbohydrates to the small intestine leads to high glucose concentrations.</li><li>- This triggers a <b>hyperinsulinaemic response</b>, resulting in subsequent hypoglycaemia.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Role of GLP1</strong></summary>
            <div>
                <ul><li>- An <u>exaggerated</u> <q><b>GLP1</b></q> response is the <b>key mediator</b>.</li><li>- Rising GLP1 levels are correlated with insulin release.</li><li>- Blockade of the GLP1 receptor with <q>exendin (9–39) amide</q> was shown to correct reactive hypoglycaemia after gastric bypass.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Role in Bariatric Surgery Weight Loss</strong></summary>
            <div>
                <ul><li>- Dumping syndrome after bariatric surgery is considered a <u>complication</u>, not a desired effect.</li><li>- No trial has demonstrated that patients with dumping syndrome lose more weight.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Diagnosis</strong></summary>
            <div>
                <ul><li>- In clinical practice, dumping syndrome is often missed, and diagnosis is delayed.</li><li>- A key clinical clue is <b>profound fatigue</b> after meals with the need to lie down.</li></ul>
                
        <details>
            <summary><strong>Symptom-Based Questionnaires</strong></summary>
            <div>
                <ul><li>- The consensus panel did <u>not endorse</u> the use of questionnaires like Sigstad’s score or the Arts dumping questionnaire for diagnosis.</li><li>- Their diagnostic accuracy and sensitivity to therapy are not well-established, especially after bariatric surgery.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Diagnostic Testing</strong></summary>
            <div>
                <ul><li>- A structured approach to confirm the diagnosis is crucial.</li></ul>
                
        <details>
            <summary><strong>Spontaneous Hypoglycaemia</strong></summary>
            <div>
                <ul><li>- Spontaneous plasma glucose levels <q><b><2.8 mmol/l (50mg/dl)</b></q> are indicative of late dumping syndrome.</li><li>- A cutoff of <3.3 mmol/l (60mg/dl) was <u>not endorsed</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Modified Oral Glucose Tolerance Test (OGTT)</strong></summary>
            <div>
                <ul><li>- The <b>preferred diagnostic test</b> for dumping syndrome.</li></ul>
                
        <details>
            <summary><strong>Procedure</strong></summary>
            <div>
                <ul><li>- Patient ingests <q><b>75g of glucose</b></q> in solution after an overnight fast.</li><li>- Measure glucose, haematocrit, pulse rate, and blood pressure before and at 30-min intervals for up to <q>180 minutes</q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Criteria for <u>Early</u> Dumping Syndrome</strong></summary>
            <div>
                <ul><li>- Test is considered positive if at 30 minutes there is:</li><li>- An increase in haematocrit <q><b>>3%</b></q></li><li>- OR an increase in pulse rate <q><b>>10 bpm</b></q> (this is the most sensitive sign).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Criteria for <u>Late</u> Dumping Syndrome</strong></summary>
            <div>
                <ul><li>- Test is considered positive based on the development of late hypoglycaemia.</li><li>- Glucose nadir <q><b><50 mg/dl</b></q> between 60–180 minutes after ingestion.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Tests with <u>No Established Value</u></strong></summary>
            <div>
                <ul><li>- The consensus panel did not find sufficient evidence to recommend these tests for routine diagnosis.</li></ul>
                
        <details>
            <summary><strong>Continuous Glucose Monitoring (CGM)</strong></summary>
            <div>
                <ul><li>- The diagnostic value of CGM has <u>not been established</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Mixed Meal Tolerance Test</strong></summary>
            <div>
                <ul><li>- <u>Not considered superior</u> to the modified OGTT.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Gastric Emptying Test</strong></summary>
            <div>
                <ul><li>- Has <b>low sensitivity and specificity</b> for dumping syndrome.</li><li>- Its use to confirm a diagnosis is <u>not recommended</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Treatment</strong></summary>
            <div>
                <ul><li>- A stepwise approach is recommended, starting with conservative measures.</li></ul>
                
        <details>
            <summary><strong><b>First-Line</b>: Dietary Modification</strong></summary>
            <div>
                <ul><li>- The <b>initial approach</b> and is usually beneficial for the majority of patients.</li></ul>
                
        <details>
            <summary><strong>Key Dietary Advice</strong></summary>
            <div>
                <ul><li>- <u>Reduce meal size</u>: Eat smaller, more frequent meals.</li><li>- <u>Delay fluid intake</u>: Wait at least <q>30 minutes</q> after meals to drink fluids.</li><li>- <u>Eliminate simple carbohydrates</u>: Avoid sweet foods and drinks.</li><li>- <u>Increase complex nutrients</u>: Eat a diet high in fibre and rich in protein.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Lying Down Post-Meal</strong></summary>
            <div>
                <ul><li>- Advising patients to lie down for 30 minutes after meals was <u>not endorsed</u> due to a lack of evidence.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Second-Line</b>: Pharmacotherapy</strong></summary>
            <div>
                <ul><li>- To be considered in patients who do not respond to dietary modification.</li></ul>
                
        <details>
            <summary><strong><b>Acarbose</b></strong></summary>
            <div>
                <ul><li>- An alpha-glycosidase inhibitor that slows carbohydrate absorption.</li><li>- Particularly effective for symptoms of <b>late dumping syndrome</b>.</li><li>- Effect on early dumping syndrome is unclear.</li></ul>
                
        <details>
            <summary><strong>Dosing & Side Effects</strong></summary>
            <div>
                <ul><li>- Usual dose: <q><b>50–100 mg</b></q> three times a day with meals.</li><li>- Main adverse effect is <q>flatulence</q> and related GI symptoms.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Somatostatin Analogues</b> (e.g., Octreotide)</strong></summary>
            <div>
                <ul><li>- The <b>preferred option</b> for patients unresponsive to diet and/or acarbose.</li><li>- Effective for symptoms of <b>both early and late</b> dumping syndrome.</li></ul>
                
        <details>
            <summary><strong>Mechanism of Action</strong></summary>
            <div>
                <ul><li>- Slows gastric emptying and small bowel transit.</li><li>- Inhibits the release of various GI hormones.</li><li>- Inhibits insulin secretion.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Formulations</strong></summary>
            <div>
                <ul><li>- <b>Short-acting</b> formulations are considered <u>more effective</u> than long-acting ones for symptom control.</li><li>- However, the need for repeated daily injections is a major limitation of short-acting forms.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Therapies <u>Not Endorsed</u></strong></summary>
            <div>
                <ul><li>- The panel did not support the use of the following agents due to insufficient evidence or poor tolerability.</li></ul>
                
        <details>
            <summary><strong>Dietary Supplements (Viscosity Agents)</strong></summary>
            <div>
                <ul><li>- Agents like guar gum, pectin, and glucomannan are not recommended.</li><li>- Rationale is to slow nutrient release, but palatability and tolerability are poor.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Diazoxide</strong></summary>
            <div>
                <ul><li>- A potassium channel activator that inhibits insulin release.</li><li>- Its use is <u>not established</u>, with only anecdotal evidence available.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Third-Line</b>: Refractory Cases</strong></summary>
            <div>
                <ul><li>- For severe cases unresponsive to diet and pharmacotherapy, options are limited and evidence is scarce.</li></ul>
                
        <details>
            <summary><strong>Enteral Nutrition</strong></summary>
            <div>
                <ul><li>- Constant enteral nutrition via a feeding jejunostomy or gastrostomy has <u>no established value</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Surgical Re-intervention</strong></summary>
            <div>
                <ul><li>- A <b>conservative, non-surgical approach is recommended</b> as patients may improve over time.</li><li>- Surgical interventions (e.g., bypass reversal, pouch restriction, pancreatic resection) have <u>uncertain outcomes</u> and are not endorsed.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Summary of Recommendations (Table 5)</strong></summary>
            <div>
                <ul><li>- A high-level overview of the consensus recommendations.</li></ul>
                
        <details>
            <summary><strong>Diagnosis</strong></summary>
            <div>
                <ul><li>- Suspect based on clinical history.</li><li>- Use <b>modified OGTT</b> for confirmation (Pulse >10bpm or Hct >3% for early; Glucose <50mg/dl for late).</li><li>- Questionnaires and gastric emptying tests have <u>no proven diagnostic value</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Treatment</strong></summary>
            <div>
                <ul><li>- 1st Line: <b>Dietary intervention</b> (eliminate simple carbs, small meals).</li><li>- 2nd Line: <b>Acarbose</b> (especially for late dumping) or <b>Somatostatin analogues</b> (for early and late).</li><li>- 3rd Line: Surgical re-interventions have <u>uncertain outcomes</u> and are not recommended.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
    </div>
    
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
